Clinical characteristics related to the number of t(14;18)-positive cells per 75 000 cells in blood before the start of therapy
| . | Below the median of 262 (n = 17) (%) . | Above the median of 262 (n = 17) (%) . | P . |
|---|---|---|---|
| Stage IV | 47 | 88 | .01 |
| Involved bone marrow* | 50 | 94 | .01 |
| Bulky disease | 71 | 29 | .02 |
| Prior wait-and-see | 29 | 12 | NS |
| . | Below the median of 262 (n = 17) (%) . | Above the median of 262 (n = 17) (%) . | P . |
|---|---|---|---|
| Stage IV | 47 | 88 | .01 |
| Involved bone marrow* | 50 | 94 | .01 |
| Bulky disease | 71 | 29 | .02 |
| Prior wait-and-see | 29 | 12 | NS |
NS indicates not significant.
Analyzed in 32 of 34 patients.